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Abstract
Objectives: Fungus Cordyceps militaris has been used as a herbal tonic in traditional Chinese medicine, which could be surface 
liquid-cultured for mycelia production. To evaluate the potential of  polysaccharides obtained from mycelia of  Cordyceps militaris 
(PS-MCM) for attenuation of  side-effects of  chemotherapy.
Methods: Doxorubicin was used to induce cytotoxicity in THP-1 monocytes and EL-4 T cells, and the effects of  PS-MCM on 
cell viability and cytokine production were detected on doxorubicin-treated THP-1 and EL-4 cells.
Results: PS-MCM reduced doxorubicin-induced cell death and promoted cell proliferation in THP-1 and EL-4 cells. Moreover, 
PS-MCM elevated the level of  cytokines associated with immune-modulation of  THP-1 and EL-4 cells.
Conclusion: These findings indicate that PS-MCM has potential for development as a functional food to counteract side effects 
of  chemotherapy.
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Introduction
Combined immunotherapy and chemotherapy is one of  
the most efficient strategies for treating cancer. It is im-
portant to design an effective treatment program which 
can optimize immunotherapy and chemotherapy to di-
minish side effects.1 Clinical evidence shows that elim-
inating cancer via the immune system is promising and 
will propel more research in immunotherapy. Therefore, 
many studies have been done to use the most appropriate 
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strategies to meet different performance objectives. The 
use of  complementary and alternative medicine has be-
come a popular option to support the conventional ther-
apy in many areas.2-4 For example, many herbal formulas 
and remedies based on the traditional Chinese medicine 
are well accepted among cancer patients with Chinese 
background.5-7
The fungus Cordyceps has been used as a herbal tonic 
in traditional Chinese medicine for over 300 years. Nu-
merous studies have recently reported the anticancer ac-
tivity of  C. sinensis, against B16 melanoma,8 leukemia,9 
thyroid carcinoma,10 hepatocellular carcinoma,11 and 
renal cancer cells.12 Cordycepin is a crucial bioactive com-
pound derived from C. militaris. The inhibitory effect of  
cordycepin on cancer was diminished by adenosine de-
aminase catalysis in vivo.13  We have demonstrated the 
anti-oral cancer activity of  water extract isolated from the 
mycelia of  surface liquid-cultured C. militaris.14 In addi-
tion, polysaccharides were isolated from the mycelium of  
submerged-fermented C. militaris by liquid static culture,15 
which have been shown to stimulate immune activity via 
promotion of  lymphatic spleen cell proliferation and cy-
tokines production.16
The chemotherapeutic drug doxorubicin has been found 
to cause cell toxicity of  normal immunocytes during che-
motherapy, leading to loss of  immune activity and oth-
er side-effects. Moreover, a healthy immune system was 
deemed irrelevant for treating cancer in the context of  
chemotherapy.17 The immune cells interact with the can-
cer cells and the immune system is fully capable of  kill-
ing tumor cells. However, immune cells have trouble to 
recognizinge them due to tumor-induced immune sup-
pression.18  Evidence from a recent study has shown that 
immune-stimulatory activity mediated by herbs could 
attenuate side-effects caused by chemotherapy.19 There-
fore, the aim of  this study was to evaluate the potential 
of  polysaccharides obtained from the mycelia of  surface 
liquid-cultured C. militaris (PS-MCM) on immune-stimu-
latory activity against side-effects of  chemotherapy.
Materials and methods
Sample isolation
C. militaris (BCRC34380) was obtained from the Biore-
source Collection and Research Center (Hsinchu, Tai-
wan).The liquid seed culture was inoculated with a my-
celium mat from a stock slant and cultured in a 500mL 
conical flask containing 200 mL of  the medium (10 g/L 
peptone, 30 g/L glucose, 0.5 g/LMgSO4, 0.5 g/L K2H-
PO4, and 0.5 g/L KH2PO4) at 25°C on a rotary shaker at 
150 rpm for 7 days for maintenance. The cultured mycelia 
were collected and freeze dried, and the mycelium powder 
was dissolved in water and heated for 60 minutes at 60°C 




THP-1, a human monocytic leukemia cell line, was ob-
tained from the Bioresource Collection and Research 
Center (BCRC 60430; Food Industry Research and De-
velopment Institute, Hsinchu, Taiwan). Cells were main-
tained in RPMI1640medium supplemented with 10% 
FBS, streptomycin (100 mg/mL), penicillin (100 U/mL), 
50 μM β-mercaptoethanol, and 5.5 mM D-glucose in a 
5% CO2 incubator at 37oC. EL-4 murine T-lymphoma 
cells were purchased from the Bioresource Collection 
and Research Center (Hsinchu, Taiwan). EL-4 cells were 
cultured in RPMI-1640 medium supplemented with 10% 
heat-inactivated FBS. Confluent cells were sub-cultured 
at a ratio of  1:3 in a 10 cm dish, and media were changed 
twice a week. Cells were cultured at 37°C in a humidified 
atmosphere of  5% CO2.
 
Cell viability
THP-1 and EL-4 cells were treated by doxorubicin with 
various polysaccharides obtained from the mycelia of  sur-
face liquid-cultured C. militaris (PS-MCM) for 24 hours. 
Cell viability was measured using the MTT reduction as-
say. Incubation was terminated by media aspiration and 
addition of  5 mg/mL of  MTT working solution to each 
well. Formazane formation was terminated after 3 hours 
by removal of  the MTT solution. Subsequently, appropri-
ate amounts of  DMSO were added to each well to solu-
bilize the formazane. The formazane-containing samples 
were transferred to a new 96-well plate and the absor-
bance at 590 nm was measured with a spectrophotometer 
(U-2000, Hitachi, Tokyo, Japan).20,21
Cytokines assay
Quantification of  cytokines was carried out by ELISA 
kits. After 24 hours of  incubation, the culture medium of  
control and treated cells was collected, centrifuged, and 
stored at −80°C until tested. The levels of  interleukin 
(IL)-1beta, tumor necrosis factor (TNF)-alpha, interferon 
(IFN)-gamma, IL-6, and IL-4 released into culture medi-
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um were determined with ELISA kits from eBioscience 
(San Diego, CA, USA).
 
Statistical analysis
Experimental results were analyzed in triplicates and ex-
pressed as means ± standard deviation (SD). The results 
were subjected to one-way analysis of  variance (ANOVA) 
and Duncan’s multiple range tests and the significance of  
differences between sample means was calculated; and 
p≤0.05 was considered significant.
Results
Effect of  PS-MCM on cell viability of  THP-1 monocytes
The data showed that biomass of  mycelium from C. mil-
itaris was significantly increased in porcine liver extracts 
medium when compared with the basal medium or the 
de-fat soybean extracts medium by surface liquid cultiva-
tion (Supplemental Figure 1A). Moreover, we evaluated 
polysaccharides production of  surface liquid-cultured C. 
militaris by different substrates, including polysaccharides 
obtained from mycelia of  C. militaris grown in basal medi-
um, polysaccharides obtained from mycelia of  C. militaris 
grown in porcine liver extracts medium, and polysaccha-
rides obtained from mycelia of  C. militaris grown in de-
fat soybean medium. Results are shown in Supplemental 
Figure 1B. The ability of  polysaccharide production by 
C. militaris was greater in basal medium than porcine liv-
er extracts medium and de-fat soybean medium, reveal-
ing that protein and nitrogen resource may suppress the 
production of  polysaccharides. There were no significant 
differences in DPPH and ABTS free radicals scavenging 
activity, and chelating activity among the groups (Supple-
mental Figure 2A and 2B).
 
 
Figure 1. Effects of PS-MCM on cell proliferation in THP-1 cells  
for 24 h.. Results are expressed as mean ± SD (n = 3) 
The THP-1 monocytes were treated with various doses 
(50, 100, and 250 μg/mL) of  PS-MCM isolated from my-
celia of  C. militaris grown in basal medium for 24 hour-
sand the cell viability were determined by MTT assay. The 
results showed that BM PS-MCM promoted cell prolifer-
ation of  THP-1 monocytes in a dose-dependent manner 
(Figure 1).
Doxorubicin is a drug used in chemotherapy. The THP-
1 monocytes were treated with various doses of  doxo-
rubicin for 24 hours, and cell viability was measured by 
MTT assay. As shown in Figure 2, when compared to the 
control group, doxorubicin (0.5, 1, 2.5, and 5 μM, respec-
tively) treatment significantly resulted in cell toxicity in 
THP-1 monocytes, and the cell viabilities were 95.8, 74.9, 
61.3, and 23.9%, respectively. Some 2.5 μM of  doxo-
rubicin was used to induce cell toxicity for suppressing 
immune activity of  the cells, and the protective effects 
of  PS-MCM on doxorubicin-treated THP-1 monocytes 
against side effects in chemotherapy were investigated. 
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Figure 2. Inhibitory effects of doxorubicin on cell viability of THP-1 
cells for 24 h. Results are expressed as mean ± SD (n = 3) 
As shown in Figure 3, when compared with the blank 
group, PS-MCM treatment significantly increased the cell 
proliferation of  THP-1 monocytes, whereas 2.5 μM of  
doxorubicin treatment markedly decreased cell viabili-
ty. Moreover, PS-MCM treatment attenuated doxorubi-
cin-induced toxic effects in THP-1 monocytes.
Effects of  PS-MCM on immune regulation in doxorubi-
cin-treated THP-1 monocytes
 
Figure 3. Effects PS-MCM combined with doxorubicin on cell viability 
of THP-1 cells for 24 h. Results are expressed as mean ± SD (n = 3). 
Significant difference was shown by different letters (p < 0.05). 
PS: PSMCM; D: doxorubicin. 
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The levels of  IL-1beta, TNF-alpha, IFN-gamma, and 
IL-6 were detected after treating with PS-MCM or/
and doxorubicin in THP-1 monocytes. The results dis-
played in Table 1 show that, 250 μg/mL of  PS-MCM 
treatment efficiently promoted the production of  cyto-
kines in THP-1 monocytes when compared to the blank 
group. Reciprocal results were obtained with doxorubicin 
treatment. None the less, treating with PS-MCM poten-
tially reversed the immune-stimulatory activity in doxo-
rubicin-induced THP-1 monocytes for the generation of  
L-1beta, TNF-alpha, IFN-gamma, and IL-6.
 
Effect of  PS-MCM on cell viability of  EL-4 T cells
The EL-4 T cells were treated with various doses (50, 
100, and 250 μg/mL) of  PS-MCM for 24 hours and the 
cell viability were determined by MTT assay. The results 
indicated that PS-MCM promoted cell proliferation of  
EL-4 T cells in a dose-dependent manner (Figure 4).
 
 
Figure 4. Effects of PS-MCM on cell proliferation of EL-4 cells 
for 24 h. Results are expressed as mean ± SD (n = 3). PS: PSMCM; D: doxorubicin 
In addition, The EL-4 T cells were treated with various 
doses of  doxorubicin for 24 hours, and the cell viability 
was measured by MTT assay. As shown in Figure 5, when 
compared with the control group, doxorubicin signifi-
cantly caused cell toxicity in EL-4 T cells. Some 2.5 μM 
of  doxorubicin was used to induce cell toxicity for sup-
pressing immune activity of  the cells, and the protective 
effects of  PS-MCM on doxorubicin-treated EL-4 T cells 
against side effects in chemotherapy were investigated. 
The results in Figure 6 show that, PS-MCM significantly 
increased cell proliferation of  EL-4 T cells when com-
pared with the blank group, and 2.5 μM of  doxorubi-
cin markedly suppressed cell viability, whereas PS-MCM 
attenuated doxorubicin-induced toxic effects in EL-4 T 
cells.
Effects of  PS-MCM on immune regulation in doxo-
rubicin-treated EL-4 T cells
The levels of  IFN-gamma and IL-4 were detected after 
treating with PS-MCM or/and doxorubicin in EL-4 T 
cells. Results in Table 2, show 250 μg/mL of  PS-MCM 
treatment increased the production of  cytokines in EL-4 
T cells when compared to the blank group, whereas doxo-
rubicin treatment did not affect the level of  cytokines in 
EL-4 cells. With increasing dosage, PS-MCM potentially 
promoted the immune-stimulatory activity for the pro-
duction of  IFN-gamma and IL-4 in doxorubicin-treated 
EL-4 T cells.
Discussion
THP-1 cells have been extensively used to study func-
African Health Sciences Vol 19 Issue 2, June, 20192160
tion, mechanism, signaling pathways and nutrient or drug 
transport of  monocytes/macrophages.22 THP-1 cells can 
accurately mimic human monocytes and can differentiate 
into macrophages if  properly incubated with the appropri-
ate stimuli.23,24 Due to their uniform genetic background, 
THP-1 cells are frequently used as a model system for the 
study of  monocytes abolishing donor variability.25 This 
cell line has also been employed to study cardiovascular 
diseases,24 for dermatological tests of  new cosmetics,26 
and toanalyze the effect of  food-derived products in the 
immune response.23 Our data showed that PS-MCM exer-
tedan M1-like induction in monocytes, inducing cytokines 
production such as IL-1beta and IFN-gamma (Table 1), 
and attenuated cytotoxic effects caused by chemothera-
peutic drug doxorubicin in monocytes (Figure 1; Figure 2; 
Figure 3). Recently, polysaccharides have been reported to 
display immune stimulatory effects via inducing cytokines 
production in THP-1 monocytes.27,28 Cytokines IL-1beta, 
TNF-alpha, and IFN-gamma have been found to act as 
immune regulators and suppress cancer cells.29,30 Dox can 
cause a severe decrease in the number of  white blood 
cells, red blood cells, and platelets in cancer patients. The 
accumulation of  Dox in white blood cells has been inves-
tigated, and this accumulation in monocytes was greater 
than granulocytes and lymphocytes, suggesting that Dox 
resulted in cytotoxic effects and immune-suppression in 
monocytes.31 Taken together, our results suggest that PS-
MCM has potential to be used as a novel agent for immu-
notherapy in cancer patients by up-regulating monocytes 
survival and cytokines secretion.
T cells encounter an antigen on antigen presenting-
cells (APCs), they can develop into at least two distinct 
T helper (Th) type cells: (1) Th1 cells that secrete IL-2, 
IFN-gamma, TNF-alpha; and (2) Th2 cells that secrete 
IL-4, IL-5, andIL-13.32 In the present study, doxorubicin 
treatment resulted in cytotoxicity of  EL-4 T cells, where-
as the negative effects of  doxorubicin were blocked by 
PS-MCM treatment in EL-4 T cells. Moreover, IFN-gam-
ma level was markedly increased in EL-4 cells after treat-
ing with PS-MCM, which is an indicator for activation 
of  T cells, while there were no significant change in IL-4 
levels of  PS-MCM-treated EL-4 cells. The results indi-
cated that PS-MCM elevated immune activity of  EL-4 T 
cells as well as THP-1 monocytes against side effects in 
chemotherapy.
Recently, several searchers have investigated the regulato-
ry potential of  polysaccharides isolated from C. militaris, 
including Luo et al who suggested that two polysaccha-
ride fractions by water extraction significantly promoted 
proliferation of  lymphatic spleen cell in mice16. Another 
polysaccharide (CMPB90-1) was isolated from C. militaris 
by alkaline extraction, showing that this polysaccharide 
is composed of   (1→6)-linked α-d-glucopyranosyl and 
(1→3)-linked α-d-glucopyranosyl residues33. In this study, 
CMPB90-1 has been found to be associated with prolif-
eration of  spleenic lymphocytes, enhanced cytoxicity of  
NK cells, and up-regulated T cell subpopulation.33 More-
over, the content of  beta-glucan in polysaccharide isolat-
ed from C. militaris fermented with Pediococcus pentosa-
ceus has been measured, and the polysaccharides exerted 
immune-enhancing activity in the CY-induced immuno-
suppressed mice.34 In addition to immune-stimulation, 
the C. militaris-derived polysaccharides also showed the 
anti-tumor and anti-fatigue potentials.35,36 Taken together, 
immunotherapy is the “treatment of  disease by induc-
ing, enhancing, or suppressing an immune response.33 
Chemotherapy is a type of  cancer treatment that uses 
chemo-drugs to kill cancer cells. As cancer cells divide 
more quickly than healthy cells, chemotherapeutic drugs 
effectively target those cells. Fast growing, normal cells 
such as monocytes and T cells, may also be damaged by 
chemo-drugs. Due to negative immune regulation, che-
motherapeutic drugs have different side effects such as 
fatigue and disgusting. Therefore, functional foods sup-
plements toregulate immune function may abolish or at-
tenuate these side effects. 
Conclusion
Here we found that PS-MCM increased the cell prolifer-
ations of  monocytes and T cells and promoted immune 
activity through cytokines regulation. It is considered that 
PS-MCM could be developed as functional foods for at-
tenuating side effects in cancer patients with chemother-
apy. 
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